Abstract

Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Relationship between self-disclosure and anticipatory grief in patients with advanced lung cancer: the mediation role of illness uncertainty.
Yinglan Wang ... Nan Zhang
Frontiers in psychology | VOL. 14
Yinglan Wang, et. al.Yinglan Wang ... Nan Zhang
08 Dec 2023
Clinical phase I/II study with the insulin-like growth factor-1 receptor inhibitor AXL1717: Future implications for patients with squamous non-small cell lung carcinoma?
S Ekman ... A Bergman
Journal of Clinical Oncology | VOL. 28
S Ekman, et. al.S Ekman ... A Bergman
20 May 2010
P2.04-65 Peptide-Based Cancer Vaccine Shortened the Overall Survival of a Large Portion, but Not All, of Advanced Cancer Patients
A Yamada ... K Yoshiyama
Journal of Thoracic Oncology | VOL. 14
A Yamada, et. al.A Yamada ... K Yoshiyama
01 Oct 2019
Furthering the clinical development of navicixizumab in advanced epithelial ovarian cancer patients with a population pharmacokinetic model and exploratory exposure-safety-efficacy response analyses (225)
Kevin Dykstra ... Kerry Culm-Merdek
Gynecologic Oncology | VOL. 166
Kevin Dykstra, et. al.Kevin Dykstra ... Kerry Culm-Merdek
01 Aug 2022
View more papers

More From: Future Oncology

Paper Title
Journal
Date
Author
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA
Kerigo Ndirangu ... Genevieve Meier
Future Oncology | VOL. -
Kerigo Ndirangu, et. al.Kerigo Ndirangu ... Genevieve Meier
17 May 2024
Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research
Maria Baz Ibrahim ... Etienne Rouleau
Future Oncology | VOL. -
Maria Baz Ibrahim, et. al.Maria Baz Ibrahim ... Etienne Rouleau
09 May 2024
Phase II trial of niraparib for BRCA -mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B
Yasuyuki Kawamoto ... Shunsuke Kondo
Future Oncology | VOL. -
Yasuyuki Kawamoto, et. al.Yasuyuki Kawamoto ... Shunsuke Kondo
22 Apr 2024
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study
Beilei Cai ... Teddy Saliba
Future Oncology | VOL. -
Beilei Cai, et. al.Beilei Cai ... Teddy Saliba
17 Apr 2024
View more papers